Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $16.61 USD
Change Today +0.17 / 1.03%
Volume 49.7K
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bruce L. A. Carter Ph.D.

AgeTotal Calculated CompensationThis person is connected to 194 board members in 11 different organizations across 17 different industries.

See Board Relationships


Dr. Bruce L. A. Carter, Ph.D., served as the Chief Executive Officer at ZymoGenetics Inc., from April 1998 to January 2009. Dr. Carter served as President of ZymoGenetics from 1998 to July 2, 2007 and from 1988 to 1995. He led the negotiations that established ZymoGenetics as an independent company from Novo Nordisk in 2000. He served as a Lecturer of Trinity College, University of Dublin from 1975 to 1982. He has over 25 years of pharmaceutical experience. From 1994 ...

Read Full Background

Corporate Headquarters*

1616 Eastlake Avenue East
Seattle, Washington 98102

United States

Phone: 206-682-0645
Fax: 206-682-0648

Board Members Memberships*

Executive Chairman
Member of the Board of Directors
Director and Member of Nominating & Governance Committee
Independent Director, Chairman of Science, Technology & Operations Committee and Member of Risk Management Committee
Chairman of The Board, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Director, Chairman of Compensation Committee and Member of Audit Committee
Independent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee


Nottingham University
Queen Elizabeth College, University Of London

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$91,917
Total Calculated Compensation$150,117
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMDZ:US $16.61 USD +0.17


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNE DESIGN CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at